We become the most trusted partner of our customers and make a better life for patients
Pipeline
KP-VR2
Program Target
VEGF-A, PLGF, VEGF-B
Disease Indication
wet AMD
Wet age-related macular degeneration (Wet AMD) abnormal new blood vessels form during choroidal neovascularization leading cause of vision loss symptoms: blurred/black spots in central vision vision loss negatively impacts patient’s quality of life significantly
KP-VR2 mechanism
VEGF/PLGF blocking Fc fusion protein Potential Best–in-Class Product Against Anti-VEGF agents A new anti-angiogenesis drug with longer duration of action
PHONE
031-8025-6901
FAX
031-888-6699
Copyright 2021 KPBioscience. All right reserved.
Privacy | service | Contact us
